STRATA Skin Sciences (SSKN) Total Debt (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.25% |
| Sep 30, 2025 | 0.26% |
| Jun 30, 2025 | 0.26% |
| Mar 31, 2025 | 0.26% |
| Dec 31, 2024 | 0.26% |
| Sep 30, 2024 | 0.26% |
| Jun 30, 2024 | 0.26% |
| Mar 31, 2024 | 0.21% |
| Dec 31, 2023 | 0.19% |
| Sep 30, 2023 | 0.19% |
| Jun 30, 2023 | 99.37% |
| Mar 31, 2023 | 0.55% |
| Dec 31, 2022 | 0.55% |
| Sep 30, 2022 | 0.54% |
| Jun 30, 2022 | 0.53% |
| Mar 31, 2022 | 0.51% |
| Dec 31, 2021 | 0.51% |
| Sep 30, 2021 | 1,356.40% |
| Jun 30, 2021 | -80.22% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Sep 30, 2019 | 0.51% |
| Jun 30, 2019 | 0.47% |
| Mar 31, 2019 | 0.46% |
| Dec 31, 2018 | -8.54% |
| Sep 30, 2018 | 10.48% |
| Jun 30, 2018 | -28.78% |
| Mar 31, 2018 | 0.38% |
| Dec 31, 2017 | -4.99% |
| Sep 30, 2017 | -6.92% |
| Jun 30, 2017 | 0.52% |
| Mar 31, 2017 | 0.46% |
| Dec 31, 2016 | 0.53% |
| Sep 30, 2016 | 0.54% |
| Jun 30, 2016 | 0.01% |
| Mar 31, 2016 | 15.16% |
| Dec 31, 2015 | 11.34% |
| Sep 30, 2015 | 215.32% |
| Sep 30, 2014 | -59.23% |
| Jun 30, 2014 | -57.95% |
| Mar 31, 2014 | 180.57% |
| Jun 30, 2013 | 1.44% |